Texas Institute for Neurological Disorders - Sherman — Sherman, Texas

Texas Institute for Neurological Disorders - Sherman is a clinical research site located in Sherman, Texas, United States 75092.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Institute for Neurological Disorders - Sherman has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.

Sponsors: Sanofi, Zenas BioPharma (USA), LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman

Browse all research sites in Texas · View every site in Sherman

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Institute for Neurological Disorders - Sherman?

Texas Institute for Neurological Disorders - Sherman has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Institute for Neurological Disorders - Sherman conducted?

Texas Institute for Neurological Disorders - Sherman has 3 clinical trials on record, with 3 currently active. Their work covers Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.

Is Texas Institute for Neurological Disorders - Sherman accredited by Crixeo Clinical Trials?

Texas Institute for Neurological Disorders - Sherman has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Institute for Neurological Disorders - Sherman?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.